initi
investig
vitro
impact
singl
mix
iav
sp
infect
mdm
firstli
activ
replic
iav
assess
qrtpcr
quantif
new
infecti
viral
particl
cell
supernat
fig
b
iav
titer
increas
time
singl
infect
iav
correl
increas
product
negativestrand
iav
rna
maximum
viral
replic
observ
hour
postinfect
time
rna
replic
quantiti
infecti
particl
decreas
vitro
model
subsequ
challeng
iavinfect
mdm
sp
signific
impact
product
new
infecti
viral
particl
fig
togeth
result
indic
permiss
product
infect
mdm
iav
secondli
evalu
whether
mdm
permiss
iav
sp
infect
presenc
pneumococci
within
iav
spinfect
primari
mdm
confirm
h
postinfect
fig
suggest
mdm
permiss
viral
bacteri
coinfect
earli
step
infect
importantli
confoc
codetect
mix
iav
sp
effect
follow
h
postinfect
due
bactericid
impact
sp
intern
within
human
macrophag
h
data
shown
thirdli
evalu
impact
singl
mix
infect
iav
sp
mdm
viabil
mix
infect
significantli
decreas
cell
viabil
total
cell
death
hour
postinfect
p
compar
singl
sp
iav
infect
total
cell
death
respect
fig
taken
togeth
result
confirm
human
mdm
permiss
mix
viral
bacteri
infect
investig
innat
immun
respons
orchestr
iav
spinfect
human
mdm
firstli
evalu
express
gene
involv
innat
adapt
immun
respons
tabl
major
differentiallyexpress
gene
summar
fig
express
profil
indic
overal
induct
gene
relat
jakstat
tlr
signal
pathway
inde
interferonstimul
gene
isg
screen
includ
foldchang
fc
fc
fc
upregul
follow
mix
infect
compar
uninfect
cell
close
relat
fc
fc
fc
also
found
upregul
mix
infect
cell
secondli
investig
endogen
microrna
express
profil
iav
spinfect
mdm
select
microrna
found
differentiallyexpress
differ
infect
condit
shown
fig
tabl
overexpress
singl
iav
fc
singl
sp
fc
mix
iavsp
infect
fc
indic
mirna
may
play
role
innat
immun
respons
viral
bacteri
coinfect
similar
dysregul
profil
obtain
follow
iav
andor
sp
infect
human
macrophageslik
monocytesderiv
macrophag
primari
mdm
data
shown
thirdli
secret
level
variou
antivir
proinflammatori
immunomodulatori
cytokineschemokin
assay
iav
spinfect
primari
mdm
cell
supernat
observ
remark
correl
mrna
protein
express
profil
singl
mix
infect
mdm
especi
regard
express
inde
level
synergist
increas
supernat
iavinfect
mdm
expos
sp
mean
pg
compar
singl
iav
infect
pg
singl
sp
infect
pg
fig
hour
infect
cell
express
reduc
time
hour
coincid
signific
higher
proport
necrot
apoptot
cell
fig
synergist
express
similarli
observ
hour
postinfect
use
primari
mdm
fig
significantli
increas
secret
test
cytokin
chemokin
observ
postinfect
even
mix
infect
mdm
fig
interestingli
signific
product
also
observ
supernat
primari
human
airway
epitheli
cell
haec
mixedinfect
iav
sp
compar
singl
infect
fig
taken
togeth
mrna
protein
profil
result
suggest
mix
viral
bacteri
infect
mdm
induc
synergist
proinflammatori
respons
relat
interferon
jakstat
signal
pathway
signatur
iavsp
coinfect
among
microrna
screen
overexpress
iavsp
coinfect
human
mdm
remaind
studi
decid
investig
interconnect
express
innat
immun
respons
use
specif
taqman
probe
assay
target
confirm
signific
upregul
follow
mix
iav
sp
infect
human
mdm
fig
experi
mark
upregul
observ
follow
iavsp
compar
result
obtain
previous
fig
discrep
attribut
use
two
differ
approach
quantifi
express
use
targetspecif
stemloop
revers
transcript
primer
fig
allow
better
sensit
detect
compar
nonspecif
fluoresc
dye
use
fig
gener
trend
suggest
synergist
induct
respons
mix
infect
fig
hypothes
may
play
role
regul
also
synergist
upregul
mixedinfect
mdm
fig
primari
haec
fig
test
hypothesi
investig
effect
overexpress
inhibit
mdm
known
target
fig
silico
align
monitor
express
assess
effici
mimickinginhibit
mdm
expect
mrna
significantli
downregul
mdm
fc
upregul
mdm
fc
compar
mocktransfect
cell
fig
overexpress
singl
mix
iavspinfect
cell
enhanc
level
h
postinfect
wherea
partial
inhibit
downregul
express
fig
result
suggest
indirectli
regul
led
us
hypothes
control
potenti
repressor
jakstat
signal
pathway
shown
fig
sever
jakstat
signal
pathway
gene
deregul
mix
iav
spinfect
human
mdm
therefor
hypothes
directli
regul
regul
jakstat
signal
pathway
predict
target
analysi
indic
utr
suppressor
cytokin
may
target
fig
soc
protein
constitut
class
neg
regul
jakstat
signal
pathway
induc
cytokin
tlr
signal
predict
target
six
member
soc
gene
famili
transfect
human
mdm
downregul
fc
inhibit
upregul
fc
confirm
effect
regul
express
fig
moreov
synergist
downregul
iav
iavspinfect
mdm
overexpress
fig
suggest
infect
neg
regul
express
final
western
blot
confirm
express
sharpli
reduc
follow
infect
especi
mix
iav
sp
infect
fig
result
indic
strongli
induc
respons
mix
viral
bacteri
coinfect
turn
lead
downregul
jakstat
regul
mrna
protein
level
subsequ
upregul
vitro
analys
demonstr
mix
iav
sp
infect
human
mdm
haec
induc
signific
product
blood
leukocyt
respiratori
tract
epitheli
cell
activ
contribut
inflamm
pneumonia
hypothes
level
serum
patient
pneumonia
may
indic
mix
respiratori
infect
diseas
sever
part
prospect
hospitalbas
multicent
casecontrol
studi
etiolog
pneumonia
among
children
total
patient
male
femal
includ
pilot
evalu
accord
guidelin
retrospect
analysi
indic
children
clinic
sign
nonsever
pneumonia
children
sign
sever
pneumonia
main
patient
characterist
inclus
shown
tabl
patient
sever
pneumonia
signific
record
episod
dyspnea
p
cyanosi
p
lower
chest
indraw
p
dull
percuss
p
lethargi
p
chest
examin
patient
nonsever
pneumonia
moreov
pleural
effus
significantli
observ
among
critic
ill
patient
durat
hospit
significantli
longer
children
sever
pneumonia
nonsever
pneumonia
p
two
death
occur
within
group
children
retrospect
defin
sever
pneumonia
evalu
system
inflammatori
respons
case
shown
tabl
serum
level
crp
pct
gcsf
significantli
elev
serum
sampl
critic
ill
patient
patient
sever
pneumonia
significantli
higher
serum
level
nonsever
pneumonia
p
suggest
promis
prognost
marker
pneumonia
diagnost
accuraci
measur
predict
pneumonia
sever
use
bloodbas
biomark
summar
tabl
briefli
studi
optim
cutoff
valu
identifi
patient
sever
pneumonia
pg
area
receiv
oper
characterist
curv
ci
p
defin
posit
serum
level
cutoff
result
sensit
specif
posit
likelihood
ratio
prognost
valu
close
procalcitonin
pct
auc
ic
p
auc
ic
p
multiplex
pcrbase
screen
respiratori
blood
sampl
reveal
high
varieti
pathogen
associ
tabl
respiratori
virus
detect
nasal
aspir
na
patient
etiolog
bacteria
pneumonia
pneumonia
n
aureu
n
h
influenza
type
b
n
identifi
via
realtim
pcr
blood
sampl
patient
multiplex
pcr
assay
allow
identif
respiratori
bacteria
blood
patient
neg
blood
cultur
result
among
case
pcrposit
respiratori
pathogen
singl
viru
bacteria
detect
na
patient
respect
case
defin
singl
infect
group
mix
infect
group
includ
case
multipl
virus
andor
bacteria
identifi
na
without
bacteria
identifi
blood
sampl
one
virus
andor
bacteria
identifi
na
associ
blood
bacteremia
evalu
whether
serum
level
could
correl
viral
bacteri
etiolog
pneumonia
patient
mix
infect
signific
higher
serum
level
patient
singl
detect
p
tabl
stratifi
analysi
reveal
highest
serum
level
observ
among
patient
sever
respiratori
pathogen
identifi
mixeddetect
group
sever
pneumonia
pg
iqr
detail
remark
serum
level
pg
repres
higher
cutoff
valu
predict
pneumonia
sever
observ
patient
hrv
na
codetect
pneumonia
serotyp
pleural
effus
blood
concord
invitro
model
coinfect
signific
level
pg
quantifi
blood
sampl
patient
sever
bacterem
pneumococc
serotyp
pneumonia
posit
codetect
influenza
b
viru
na
taken
togeth
result
suggest
high
serum
level
significantli
associ
mix
viral
bacteri
detect
also
relat
pneumonia
pathogenesi
studi
provid
addit
vitro
clinic
data
improv
understand
immunopatholog
mix
viral
bacteri
pneumonia
fig
vitro
model
influenza
pneumococc
superinfect
human
mdm
demonstr
mix
infect
synergist
induc
releas
proinflammatori
chemokin
strongli
suggest
human
blood
leukocyt
contribut
immunopatholog
pneumonia
addit
transcriptom
omic
analys
provid
new
data
inflammatori
pathway
activ
mix
infect
relat
synergist
induct
proinflammatori
chemokin
mix
infect
cell
observ
consist
recent
studi
describ
induct
hostproteom
signatur
viral
bacteri
differentiallyexpress
gene
observ
mix
infect
mdm
transcript
factor
appear
play
crucial
role
regul
interferonstimul
gene
includ
focus
intracellular
mechan
regul
inflammatori
pathway
demonstr
novel
role
regul
observ
consist
previou
report
show
rna
viru
infect
upregul
macrophag
dendrit
cell
also
regul
suppressor
cytokin
signal
suggest
exist
mirnajakstatsoc
regulatori
pathway
viral
studi
suggest
coinfect
lead
overexpress
turn
target
downregul
jakstat
regul
consequ
increas
express
interestingli
complementari
insilico
approach
reveal
sever
microrna
found
dysregul
experi
iav
sp
coinfect
mdm
haec
might
target
sever
gene
soc
famili
play
similar
role
inde
might
target
mrna
might
target
mrna
observ
underlin
intracellular
regul
limit
contribut
sole
microrna
complex
interrelationship
numer
host
microrna
inhibitor
jakstat
signal
pathway
occur
control
host
innat
inflammatori
respons
viral
andor
bacteri
infect
clinic
major
pediatr
cap
case
studi
associ
posit
viral
andor
bacteri
detect
respiratori
microorgan
detect
case
viralvir
viralbacteri
bacterialbacteri
codetect
nasal
aspir
codetect
nasal
aspir
blood
sampl
data
consist
previou
etiolog
studi
pediatr
pneumonia
major
bacteria
identifi
blood
mainli
codetect
respiratori
virus
na
observ
high
divers
viral
bacteri
associ
biolog
sampl
children
pneumonia
comparison
iav
combin
evalu
invitro
pneumonia
case
singli
influenza
pneumococcu
infect
similar
codetect
two
pathogen
clinic
observ
nevertheless
influenza
b
ivb
viru
identifi
patient
two
posit
sp
codetect
blood
one
nontyp
strain
one
serotyp
use
molecular
type
test
ivb
combin
seem
nearest
pathogen
codetect
invitro
investig
clinic
codetect
associ
high
express
sever
pneumonia
case
definit
interestingli
translat
pilot
evalu
reveal
express
induc
sever
differ
viral
andor
bacteri
combin
immun
respons
pathogen
differ
invitro
investig
use
differ
pathogen
associ
need
better
character
mechan
involv
immunopatholog
pneumonia
cohort
highest
serum
level
identifi
among
patient
sever
pathogen
detect
sever
pneumonia
suggest
signific
role
pneumonia
pathogenesi
inde
high
plasma
level
previous
report
patient
associ
high
mortal
rate
especi
among
patient
addit
axi
relat
acut
immun
lung
injuri
lymphocyt
apoptosi
develop
sever
acut
respiratori
syndrom
sar
moreov
vivo
studi
model
influenza
pneumococc
superinfect
mice
indic
proinflammatori
chemokin
includ
play
crucial
role
influenzainduc
suscept
lung
neutrophilia
sever
immunopatholog
studi
markedli
elev
pg
combin
highest
pct
level
pg
quantifi
serum
sampl
child
die
pneumonia
serotyp
v
identifi
blood
pcr
blood
cultur
codetect
haemophilu
influenza
type
b
nasal
aspir
observ
suggest
interrelationship
codetect
elev
serum
pathogenesi
pneumonia
sever
limit
pilot
translat
studi
need
acknowledg
conclud
mix
infect
relat
elev
diseas
sever
inde
although
viral
shed
eg
hrv
hbov
common
asymptomat
children
unabl
evalu
level
immunomodul
serum
sampl
control
group
moreov
although
sampl
collect
within
first
hour
admiss
singl
blood
sampl
process
patient
therefor
larger
longitudin
studi
etiolog
sever
pneumonia
necessari
confirm
result
conclus
present
find
suggest
mix
respiratori
infect
may
play
major
interconnect
role
pathogenesi
pneumonia
clinic
assess
monitor
induc
serum
level
may
assist
clinician
improv
diagnosi
patient
manag
sever
communityacquir
pneumonia
season
influenza
viru
iav
asolomon
obtain
nation
influenza
refer
center
lyon
franc
encapsul
streptococcu
pneumonia
serotyp
sp
obtain
nation
refer
center
streptococci
depart
medic
microbiolog
univers
hospit
aachen
germani
peripher
blood
mononuclear
cell
pbmc
isol
whole
blood
four
healthi
donor
femalemal
ratio
rang
age
year
use
ficollpaqu
plu
ge
healthcar
life
scienc
littl
chalfont
unit
kingdom
monocyt
purifi
use
magnet
microbead
miltenyi
biotec
bergisch
gladbach
germani
puriti
isol
cell
consist
determin
flow
cytometri
accuri
bd
bioscienc
san
jose
california
usa
primari
mdm
obtain
day
differenti
glutamax
supplement
heatinactiv
fb
ng
mcsf
miltenyi
biotec
mdm
obtain
cultur
cell
ng
phorbol
myrist
acet
pma
invivogen
toulous
franc
hour
human
airway
epitheli
cell
haec
bronchial
cell
type
origin
old
woman
patholog
report
batch
number
provid
mucilair
epithelix
geneva
switzerland
steril
tissu
integr
teer
mucu
product
cilia
beat
frequenc
certifi
compani
multiplex
realtim
qrtpcr
perform
quantifi
iav
hemagglutinin
gene
provid
pr
ad
osterhau
depart
virolog
erasmu
medic
center
ge
rotterdam
netherland
sp
autolysin
gene
lyta
unpublish
homemad
primer
probe
design
mdm
primer
probe
lytaf
lytar
lytap
multiplex
use
onestep
rtpcr
kit
life
technolog
carlsbad
california
usa
accord
instruct
cycl
program
adjust
minut
minut
cycl
second
denatur
second
fluoresc
detect
anneal
extens
absolut
quantif
viral
hemagglutinin
pneumococc
lyta
copi
number
calcul
use
cycl
threshold
ct
valu
inhous
standard
curv
influenza
viru
pneumonia
serotyp
singl
mix
infect
cell
wash
pb
fix
paraformaldehyd
minut
room
temperatur
permeabil
triton
incub
pb
contain
bsa
human
serum
block
nonspecif
bind
mous
monoclon
antiinfluenza
viru
nucleoprotein
abcam
cambridg
unit
kingdom
goat
antimous
igg
h
l
life
technolog
use
detect
iav
rabbit
polyclon
antistreptococcu
pneumonia
antibodi
abcam
goat
antirabbit
igg
h
l
abcam
use
detect
sp
cell
imag
use
leica
dmi
microscop
equip
fluoresc
imag
total
cellular
mrna
purifi
use
rneasi
kit
qiagen
hilden
germani
reversetranscript
total
mrna
perform
use
first
strand
kit
sabiosci
hilden
germani
express
gene
involv
human
innat
adapt
immun
respons
evalu
use
pcr
array
sabiosci
accord
manufactur
recommend
method
appli
calcul
fold
chang
gene
express
gene
rel
uninfect
control
cell
use
webbas
profil
pcr
array
data
analysi
softwar
sabiosci
total
cellular
microrna
purifi
use
mirneasi
mini
kit
qiagen
reversetranscrib
use
miscript
revers
transcript
kit
qiagen
profil
mirna
perform
use
human
immunopatholog
miscript
mirna
pcr
array
kit
qiagen
accord
manufactur
instruct
data
analyz
use
miscript
mirna
pcr
array
data
analysi
web
portal
mirna
target
gene
retriev
compil
use
micrornaorg
interact
mirna
intracellular
pathway
predict
use
dianamirpath
human
primari
mdm
seed
plate
per
well
triplic
expos
influenza
asolomon
viru
iav
serumfre
condit
hour
cultur
hour
fresh
contain
fb
streptococcu
pneumonia
sp
serotyp
ad
hour
iav
infect
gentamicin
ad
hour
sp
infect
ie
hour
postinfluenza
infect
maintain
cultur
media
throughout
experi
kill
extracellular
bacteria
limit
bacteri
growth
cell
viabil
determin
flowcytometri
use
fitcannexin
v
apoptosi
detect
kit
bd
bioscienc
accord
manufactur
instruct
inhibitionmim
assay
mdm
transfect
either
nmol
inhibitor
mimic
mirna
inhibitor
neg
control
mirna
mimic
neg
control
life
technolog
optimem
life
technolog
use
invitrogen
rnaimax
lipofectaminewel
plate
hour
cell
wash
infect
previous
describ
effici
inhibitormim
evalu
hour
mix
infect
purifi
total
mirna
mirna
isol
kit
ambion
life
technolog
revers
transcript
specif
amplif
use
taqman
microrna
revers
transcript
kit
life
technolog
combin
specif
mirna
probe
assay
life
technolog
assay
fold
chang
defin
method
use
control
refer
microrna
total
mrna
purifi
transfect
infect
mdm
use
rneasi
kit
qiagen
specif
primer
use
amplifi
transform
growth
factor
f
r
f
r
f
r
f
r
rabbit
polyclon
antibodi
goat
polyclon
antiinfluenza
abcam
use
westernblot
serum
sampl
cell
cultur
supernat
screen
presenc
human
cytokin
chemokin
use
bioplex
pro
human
cytokin
standard
kit
biorad
hercul
california
usa
flexmap
analyz
luminex
austin
texa
usa
part
prospect
hospitalbas
multicent
casecontrol
studi
etiolog
pneumonia
among
children
studi
protocol
publish
total
patient
male
femal
admit
hospit
de
acosta
san
lorenzo
paraguay
includ
studi
briefli
pneumonia
case
defin
presenc
cough
andor
dyspnea
tachypnea
defin
world
health
organ
age
month
age
month
age
year
absenc
wheez
auscult
first
symptom
appear
within
last
day
radiolog
confirm
pneumonia
per
base
primari
criteria
defin
pneumonia
case
case
retrospect
reevalu
accord
pocket
book
hospit
care
children
criteria
evalu
pneumonia
sever
case
die
studi
least
one
addit
clinic
sign
includ
central
cyanosi
dull
percuss
chest
examin
prostrationlethargi
pleural
effus
observ
chest
radiographi
retrospect
includ
sever
pneumonia
group
patient
without
addit
clinic
sign
includ
nonsever
pneumonia
group
nasopharyng
aspir
na
whole
blood
sampl
collect
children
within
hour
admiss
whole
blood
sampl
use
complet
blood
count
blood
cultur
multiplex
realtim
pcr
identifi
staphylococcu
aureu
streptococcu
pneumonia
haemophilu
influenza
type
pneumonia
serotyp
defin
use
multiplex
realtim
pcr
assay
target
frequent
repres
serotyp
serogroup
accord
protocol
develop
messaoudi
et
serum
creactiv
protein
crp
assaypro
st
charl
missouri
unit
state
procalcitonin
pct
vida
brahm
quantifi
wholeblood
sampl
multiplex
realtim
non
quantit
pcr
fasttrack
diagnost
sliema
malta
use
detect
virus
five
bacteria
respiratori
specimen
na
pleural
effus
mix
detect
defin
pcrposit
multipl
virus
na
posit
blood
cultur
pcrposit
multipl
bacteria
blood
pcrposit
one
multipl
virus
na
one
multipl
bacteria
blood
identifi
pcr
blood
cultur
studi
protocol
inform
consent
statement
clinic
research
form
amend
studi
document
submit
approv
ethic
committe
instituto
de
investigacion
en
ciencia
de
la
salud
universidad
nacion
de
iicsuna
hospit
de
acosta
inform
consent
obtain
subject
involv
studi
clinic
investig
conduct
accord
principl
express
declar
helsinki
chisquar
test
fisher
exact
test
use
compar
categor
variabl
continu
variabl
nonnorm
distribut
data
compar
use
mannwhitney
utest
normal
distribut
data
compar
use
unpair
ttest
compar
analys
experiment
condit
ie
mock
iav
sp
iav
sp
perform
use
oneway
anova
tukey
posthoc
test
kruskalw
analysi
dunn
posthoc
test
receiv
oper
curv
roc
analysi
use
determin
optim
cutoff
valu
differenti
nonsever
sever
pneumonia
case
p
consid
statist
signific
statist
analys
perform
use
graphpad
prism
la
jolla
california
unit
state
cite
articl
hoffmann
j
et
al
viral
bacteri
coinfect
sever
pneumonia
trigger
innat
immun
respons
specif
enhanc
translat
studi
sci
rep
doi
publish
note
springer
natur
remain
neutral
regard
jurisdict
claim
publish
map
institut
affili
